Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics in Admitted Cirrhotics
NCT04218695Phase 4Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Aug 2020
- Primary completion
- May 2021
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bacterial infection comparing Ceftriaxone Arm with Placebo Arm (2 arms). Primary endpoint: Infections at 7 days. Started Aug 2020; status: completed.
02
Drugs
ceftriaxone
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04218695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04218695.